Disclosure by Sponsor Sample Clauses

Disclosure by Sponsor. The Institution and Principal Investigator acknowledge that the Sponsor is required by applicable laws and pharmaceutical industry codes of conduct to document and publicly disclose certain transfers of value made to healthcare professionals and healthcare organizations, and such disclosures may include information about the payments or other transfers of value provided to Institution and/or the Principal Investigator and Study Staff under this Agreement [including any financial or in- kind support that the Sponsor may provide in connection with any Manuscript]. The Sponsor may store and use information relating to the Institution, Principal Investigator and/or Study Staff and arising out of this Agreement for the purpose of its business and may publicly disclose in its discretion such information (including, but not limited to, the name and professional address of the Institution and/or the Principal Investigator and Study Staff, any financial and in-kind payments received 7.6 Zpřístupnění informací ze strany zadavatele. Zdravotnické zařízení a hlavní zkoušející berou na vědomí, že příslušné zákony a kodexy správné praxe ve farmaceutickém průmyslu zadavateli ukládají povinnost dokumentovat a veřejně zpřístupnňovat určité převody hodnot na pracovníky ve zdravotnictví a zdravotnická zařízení, a že takto mohou být zpřístupněny informace o platbách a jiných převodech hodnot poskytnutých zdravotnickému zařízení a/nebo hlavnímu zkoušejícímu a personálu studie podle této smlouvy [včetně jakékoli věcné či finanční podpory případně poskytnuté zadavatelem v souvislosti s rukopisem]. Zadavatel může uchovávat a používat informace související se zdravotnickým zařízením, hlavním zkoušejícím a/nebo personálem studie, které povstávají z této smlouvy, pro své obchodní účely, a podle svého uvážení může takové informace veřejně zpřístupnit (zejména název a adresu zdravotnického zařízení a/nebo jméno a adresu zaměstnání hlavního zkoušejícího a personálu studie, under this Agreement, the nature of the engagement and any other payment or service-related information) as may be deemed appropriate by Sponsor for the fulfillment of its transparency obligations or as may otherwise be dictated by Applicable Law or any pharmaceutical industry codes of conduct to which the Sponsor or any of its Affiliates is subject. For such purposes, the Sponsor may transfer such information to its Affiliates and/or third party service providers, who may be established in a different jurisdiction to...
Sample 1See All (4)
AutoNDA by SimpleDocs
Disclosure by Sponsor. The Institution and Principal Investigator 7.6 Zpřístupnění informací ze strany zadavatele. Zdravotnické zařízení a hlavní
Sample 1
Disclosure by Sponsor. In the interest of transparency relating to the Sponsor's financial relationships with clinical investigators and clinical study sites, the Sponsor may collect, aggregate, report and otherwise publicly disclose the funding associated with this Agreement, including payments made to institutions and payments made to individuals. Zveřejnění informací zadavatelem. V zájmu transparentnosti finančního vztahu zadavatele s klinickými zkoušejícími a pracovišti klinických studií může zadavatel shromažďovat, seskupovat, vykazovat a jinak zveřejňovat financování spojené s touto smlouvou, včetně plateb zaplacených zdravotnickým zařízením a jednotlivcům.
Sample 1
Disclosure by Sponsor. The Institution and Principal Investigator acknowledge that the Sponsor is required by applicable laws and pharmaceutical 7.6 Zveřejnění zadavatelem. Zdravotnické zařízení a hlavní zkoušející berou na vědomí, že zadavatel má povinnost plynoucí z platných zákonů
Sample 1
Disclosure by Sponsor. In the interest of transparency relating to Sponsor's financial relationships with clinical investigators and clinical study sites, Sponsor may publicly disclose the funding associated with this Agreement or if applicable any other benefit provided to Investigator or Institution by Sponsor or Covance, including, but not limited to, payments made to institutions and payments made or attributable to Investigator or other individuals directly or indirectly, and value associated with meals or travel expenses if applicable.
Sample 1
Disclosure by Sponsor. The Sponsor may publicly disclose in its discretion in accordance with the information maintained in Sponsor’s internal business records the name of the Institution and/or the Principal Investigator and Study Staff and certain information relating to this Agreement including, but not limited to, any financial and in-kind payments received under this Agreement, the nature of the engagement and any other payment or service-related information as may be deemed appropriate by Sponsor or as may be dictated by Applicable Law. Payments to the Institution for work done by specified individuals may reference both the Institution and the individual. 7.7
Sample 1
Disclosure by Sponsor. In the interest of transparency relating to Sponsor's financial relationships with clinical investigators and clinical study sites, Sponsor may publicly disclose the funding associated with this Agreement or any other benefit provided to Investigator or Provider by Sponsor or Covance, including, but not limited to, payments made to Providers and payments made or attributable to Investigator or other individuals directly or indirectly, and value associated with meals, equipment, or travel expenses if applicable. Zveřejnění finančních záležitostí zadavatelem. V zájmu transparentnosti týkající se finančních vztahů zadavatele s klinickými zkoušejícími a centry klinické studie může zadavatel zveřejnit údaje o financování spojeném s touto smlouvou nebo o jakémkoli jiném příspěvku poskytnutém zkoušejícímu nebo poskytovateli zadavatelem nebo společností Covance, včetně mimo jiné plateb poukázaných poskytovatelem a plateb poukázaných či náležejících zkoušejícímu nebo jiným osobám přímo či nepřímo a ceny spojené se stravováním, vybavením nebo cestovními náklady, pokud se vztahuje.
Sample 1
AutoNDA by SimpleDocs
Disclosure by Sponsor. The Institution and Principal Investigator acknowledge that the Sponsor is required by applicable laws and pharmaceutical industry codes of conduct to document and publicly disclose certain transfers of value made to healthcare professionals and healthcare organizations, and such disclosures may include information about the payments or other transfers of value provided to Institution and/or the Principal Investigator and Study Staff under this Agreement. The Sponsor may store and use information relating to the Institution, Principal Investigator and/or Study Staff and arising out of this Agreement for the purpose of its business and may publicly disclose in its discretion such information (including, but not limited to, the name and professional address of the Institution and/or the Principal Investigator and Study Staff, any financial and in-kind payments received under this Agreement, the nature of the engagement and any other payment or service-related information) as may be deemed appropriate by Sponsor for the fulfillment of its transparency obligations or as may otherwise be dictated by Applicable Law or any pharmaceutical industry codes of conduct to which the Sponsor or any of its 7.6 Zveřejnění zadavatelem. Zdravotnické zařízení a hlavní zkoušející berou na vědomí, že zadavatel má povinnost plynoucí z platných zákonů a kodexů farmaceutického průmyslu dokumentovat a zveřejnit určitá hodnotná plnění předaná zdravotnickým pracovníkům a zdravotnickým organizacím a že takové zveřejnění může zahrnovat informace o platbách a dalších hodnotných plněních poskytnutých zdravotnickému zařízení a/nebo hlavnímu zkoušejícímu a personálu studie podle této smlouvy. Zadavatel může uchovávat a používat informace vztahující se ke zdravotnickému zařízení, hlavnímu zkoušejícímu a/nebo personálu studie a vyplývající z této smlouvy pro účely svého podnikání a může dle svého rozhodnutí tyto informace zveřejnit (mimo jiné včetně jména a pracovní adresy zdravotnického zařízení a/nebo hlavního zkoušejícího a personálu studie, jakýchkoliv finančních nebo věcných úhrad přijatých podle této smlouvy, povahy spolupráce a jakékoliv jiné informace související s platbami nebo službami), jak může zadavatel považovat za vhodné pro splnění svých povinností ohledně transparentnosti nebo jak může být jinak nařízeno platnými zákony nebo kodexy
Sample 1

Related to Disclosure by Sponsor

  • DISCLOSURE OF FINANCIAL INFORMATION 26.1 The Customer represents and warrants that the financial information disclosed to us in his/its Application is an accurate representation of the Customer’s current financial condition. 26.2 The Customer represents and warrants that the Customer has very carefully considered the portion of the Customer’s assets which the Customer considers to be risk capital. 26.3 The Customer recognizes that risk capital is the amount of money the Customer is willing to put at risk and the loss of it would not, in any way, change the Customer’s lifestyle. 26.4 The Customer agrees to immediately inform us if the Customer’s financial condition changes in such a way to reduce the Customer’s net worth, liquid assets and/or risk capital.

  • Stockholder Has Adequate Information Stockholder is a sophisticated seller with respect to the Securities and has adequate information concerning the business and financial condition of the Company to make an informed decision regarding the sale of the Securities and has independently and without reliance upon either the Merger Sub or the Parent and based on such information as Stockholder has deemed appropriate, made its own analysis and decision to enter into this Agreement. Stockholder acknowledges that neither the Merger Sub nor the Parent has made and neither makes any representation or warranty, whether express or implied, of any kind or character except as expressly set forth in this Agreement. Stockholder acknowledges that the agreements contained herein with respect to the Securities by Stockholder are irrevocable (prior to the Termination Date).

  • Disclosure; 10b-5 The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, if any, at the time it became effective, complied in all material respects with the Securities Act and the Exchange Act and the applicable rules and regulations under the Securities Act and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus and the Prospectus Supplement, each as of its respective date, comply in all material respects with the Securities Act and the Exchange Act and the applicable rules and regulations. Each of the Prospectus and the Prospectus Supplement, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The SEC Reports, when they were filed with the Commission, conformed in all material respects to the requirements of the Exchange Act and the applicable rules and regulations, and none of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein (with respect to the SEC Reports incorporated by reference in the Prospectus or Prospectus Supplement), in light of the circumstances under which they were made not misleading; and any further documents so filed and incorporated by reference in the Prospectus or Prospectus Supplement, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and the applicable rules and regulations, as applicable, and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is required to be filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite time period. There are no contracts or other documents required to be described in the Prospectus or Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which have not been described or filed as required. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.

  • DISCLOSURE; ACCESS TO INFORMATION The Investor had an opportunity to review copies of the SEC Documents filed on behalf of the Company and has had access to all publicly available information with respect to the Company.

  • Relationship Disclosure Form The purpose of this form is to document any relationships between a bidder to an Orange County solicitation and the Mayor or any other member of Orange County, Florida. This form shall be completed and submitted with the applicable bid to an Orange County solicitation.

  • Master Servicer’s Financial Statements and Related Information For each year this Agreement is in effect, the Master Servicer shall submit to the Trustee, any NIMS Insurer, each Rating Agency and the Depositor a copy of its annual unaudited financial statements on or prior to March 15 of each year, beginning March 15, 2006. Such financial statements shall include a balance sheet, income statement, statement of retained earnings, statement of additional paid-in capital, statement of changes in financial position and all related notes and schedules and shall be in comparative form, certified by a nationally recognized firm of Independent Accountants to the effect that such statements were examined and prepared in accordance with generally accepted accounting principles applied on a basis consistent with that of the preceding year.

  • LIFE COMPANY TO PROVIDE DOCUMENTS; INFORMATION ABOUT AVIF (a) LIFE COMPANY will provide to AVIF or its designated agent at least one (1) complete copy of all SEC registration statements, Account Prospectuses, reports, any preliminary and final voting instruction solicitation material, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to each Account or the Contracts, contemporaneously with the filing of such document with the SEC or other regulatory authorities. (b) LIFE COMPANY will provide to AVIF or its designated agent at least one (1) complete copy of each piece of sales literature or other promotional material in which AVIF or any of its affiliates is named, at least five (5) Business Days prior to its use or such shorter period as the Parties hereto may, from time to time, agree upon. No such material shall be used if AVIF or its designated agent objects to such use within five (5) Business Days after receipt of such material or such shorter period as the Parties hereto may, from time to time, agree upon. AVIF hereby designates INVESCO as the entity to receive such sales literature, until such time as AVIF appoints another designated agent by giving notice to LIFE COMPANY in the manner required by Section 9 hereof. (c) Neither LIFE COMPANY nor any of its affiliates, will give any information or make any representations or statements on behalf of or concerning AVIF or its affiliates in connection with the sale of the Contracts other than (i) the information or representations contained in the registration statement, including the AVIF Prospectus contained therein, relating to Shares, as such registration statement and AVIF Prospectus may be amended from time to time; or (ii) in reports or proxy materials for AVIF ; or (iii) in published reports for AVIF that are in the public domain and approved by AVIF for distribution; or (iv) in sales literature or other promotional material approved by AVIF , except with the express written permission of AVIF . (d) LIFE COMPANY shall adopt and implement procedures reasonably designed to ensure that information concerning AVIF and its affiliates that is intended for use only by brokers or agents selling the Contracts (i.e., information that is not intended for distribution to Participants) (“broker only materials”) is so used, and neither AVIF nor any of its affiliates shall be liable for any losses, damages or expenses relating to the improper use of such broker only materials. (e) For the purposes of this Section 4.5, the phrase “sales literature or other promotional material” includes, but is not limited to, advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media, (e.g., on-line networks such as the Internet or other electronic messages), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, registration statements, prospectuses, statements of additional information, shareholder reports, and proxy materials and any other material constituting sales literature or advertising under FINRA rules, the 1933 Act, or the 0000 Xxx.

  • No Disclosure of Confidential Information The Consultant acknowledges that the Company’s trade secrets and private processes, as they may exist from time to time, and confidential information concerning the formation and development of the Bank, the Bank’s planned products, technical information regarding the Bank, and data concerning potential customers of and investors in the Bank are valuable, special, and unique assets of the Company, access to and knowledge of which are essential to the performance of the Consultant’s duties under this Agreement. In light of the highly competitive nature of the industry in which the business of the Company is conducted, the Consultant further agrees that all knowledge and information described in the preceding sentence not in the public domain and heretofore or in the future obtained by the Consultant as a result of his engagement by the Company shall be considered confidential information. In recognition of this fact, the Consultant agrees that the Consultant will not, during or after the term of this Agreement, disclose any of such secrets, processes, or information to any person or other entity for any reason or purpose whatsoever, except as necessary in the performance of the Consultant’s duties as a consultant to the Company and then only upon a written confidentiality agreement in such form and content as requested by the Company from time to time, nor shall Consultant make use of any of such secrets, processes or information for Consultant’s own purposes or for the benefit of any person or other entity (except the Company and its subsidiaries, if any) under any circumstances during or after the term of this Agreement.

  • OBLIGATIONS AND ACTIVITIES OF CONTRACTOR AS BUSINESS ASSOCIATE 1. CONTRACTOR agrees not to use or further disclose PHI COUNTY discloses to CONTRACTOR other than as permitted or required by this Business Associate Contract or as required by law. 2. XXXXXXXXXX agrees to use appropriate safeguards, as provided for in this Business Associate Contract and the Agreement, to prevent use or disclosure of PHI COUNTY discloses to CONTRACTOR or CONTRACTOR creates, receives, maintains, or transmits on behalf of COUNTY other than as provided for by this Business Associate Contract. 3. XXXXXXXXXX agrees to comply with the HIPAA Security Rule at Subpart C of 45 CFR Part 164 with respect to electronic PHI COUNTY discloses to CONTRACTOR or CONTRACTOR creates, receives, maintains, or transmits on behalf of COUNTY. 4. CONTRACTOR agrees to mitigate, to the extent practicable, any harmful effect that is known to CONTRACTOR of a Use or Disclosure of PHI by CONTRACTOR in violation of the requirements of this Business Associate Contract. 5. XXXXXXXXXX agrees to report to COUNTY immediately any Use or Disclosure of PHI not provided for by this Business Associate Contract of which CONTRACTOR becomes aware. CONTRACTOR must report Breaches of Unsecured PHI in accordance with Paragraph E below and as required by 45 CFR § 164.410. 6. CONTRACTOR agrees to ensure that any Subcontractors that create, receive, maintain, or transmit PHI on behalf of CONTRACTOR agree to the same restrictions and conditions that apply through this Business Associate Contract to CONTRACTOR with respect to such information. 7. CONTRACTOR agrees to provide access, within fifteen (15) calendar days of receipt of a written request by COUNTY, to PHI in a Designated Record Set, to COUNTY or, as directed by COUNTY, to an Individual in order to meet the requirements under 45 CFR § 164.524. If CONTRACTOR maintains an Electronic Health Record with PHI, and an individual requests a copy of such information in an electronic format, CONTRACTOR shall provide such information in an electronic format. 8. CONTRACTOR agrees to make any amendment(s) to PHI in a Designated Record Set that COUNTY directs or agrees to pursuant to 45 CFR § 164.526 at the request of COUNTY or an Individual, within thirty (30) calendar days of receipt of said request by COUNTY. XXXXXXXXXX agrees to notify COUNTY in writing no later than ten (10) calendar days after said amendment is completed. 9. CONTRACTOR agrees to make internal practices, books, and records, including policies and procedures, relating to the use and disclosure of PHI received from, or created or received by CONTRACTOR on behalf of, COUNTY available to COUNTY and the Secretary in a time and manner as determined by COUNTY or as designated by the Secretary for purposes of the Secretary determining COUNTY’S compliance with the HIPAA Privacy Rule. 10. CONTRACTOR agrees to document any Disclosures of PHI COUNTY discloses to CONTRACTOR or CONTRACTOR creates, receives, maintains, or transmits on behalf of COUNTY, and to make information related to such Disclosures available as would be required for COUNTY to respond to a request by an Individual for an accounting of Disclosures of PHI in accordance with 45 CFR § 164.528. 11. CONTRACTOR agrees to provide COUNTY or an Individual, as directed by COUNTY, in a time and manner to be determined by COUNTY, that information collected in accordance with the Agreement, in order to permit COUNTY to respond to a request by an Individual for an accounting of Disclosures of PHI in accordance with 45 CFR § 164.528. 12. XXXXXXXXXX agrees that to the extent CONTRACTOR carries out COUNTY’s obligation under the HIPAA Privacy and/or Security rules CONTRACTOR will comply with the requirements of 45 CFR Part 164 that apply to COUNTY in the performance of such obligation. 13. If CONTRACTOR receives Social Security data from COUNTY provided to COUNTY by a state agency, upon request by COUNTY, CONTRACTOR shall provide COUNTY with a list of all employees, subcontractors and agents who have access to the Social Security data, including employees, agents, subcontractors and agents of its subcontractors. 14. CONTRACTOR will notify COUNTY if CONTRACTOR is named as a defendant in a criminal proceeding for a violation of HIPAA. COUNTY may terminate the Agreement, if CONTRACTOR is found guilty of a criminal violation in connection with HIPAA. COUNTY may terminate the Agreement, if a finding or stipulation that CONTRACTOR has violated any standard or requirement of the privacy or security provisions of HIPAA, or other security or privacy laws are made in any administrative or civil proceeding in which CONTRACTOR is a party or has been joined. COUNTY will consider the nature and seriousness of the violation in deciding whether or not to terminate the Agreement.

  • Field Audits and Examination Reports; Confidentiality; Disclaimers by Lenders; Other Reports and Information By becoming a party to this Agreement, each Lender: (a) is deemed to have requested that Agent furnish such Lender, promptly after it becomes available, a copy of each field audit or examination report (each a "Report" and collectively, "Reports") prepared by Agent, and Agent shall so furnish each Lender with such Reports, (b) expressly agrees and acknowledges that Agent does not (i) make any representation or warranty as to the accuracy of any Report, and (ii) shall not be liable for any information contained in any Report, (c) expressly agrees and acknowledges that the Reports are not comprehensive audits or examinations, that Agent or other party performing any audit or examination will inspect only specific information regarding Borrowers and will rely significantly upon the Books, as well as on representations of Borrowers' personnel, (d) agrees to keep all Reports and other material, non-public information regarding Borrowers and their Subsidiaries and their operations, assets, and existing and contemplated business plans in a confidential manner; it being understood and agreed by Borrowers that in any event such Lender may make disclosures (a) to counsel for and other advisors, accountants, and auditors to such Lender, (b) reasonably required by any bona fide potential or actual Assignee or Participant in connection with any contemplated or actual assignment or transfer by such Lender of an interest herein or any participation interest in such Lender's rights hereunder, (c) of information that has become public by disclosures made by Persons other than such Lender, its Affiliates, assignees, transferees, or Participants, or (d) as required or requested by any court, governmental or administrative agency, pursuant to any subpoena or other legal process, or by any law, statute, regulation, or court order; provided, however, that, unless prohibited by applicable law, statute, regulation, or court order, such Lender shall notify Administrative Borrower of any request by any court, governmental or administrative agency, or pursuant to any subpoena or other legal process for disclosure of any such non-public material information concurrent with, or where practicable, prior to the disclosure thereof, and (e) without limiting the generality of any other indemnification provision contained in this Agreement, agrees: (i) to hold Agent and any such other Lender preparing a Report harmless from any action the indemnifying Lender may take or conclusion the indemnifying Lender may reach or draw from any Report in connection with any loans or other credit accommodations that the indemnifying Lender has made or may make to Borrowers, or the indemnifying Lender's participation in, or the indemnifying Lender's purchase of, a loan or loans of Borrowers; and (ii) to pay and protect, and indemnify, defend and hold Agent, and any such other Lender preparing a Report harmless from and against, the claims, actions, proceedings, damages, costs, expenses, and other amounts (including, attorneys fees and costs) incurred by Agent and any such other Lender preparing a Report as the direct or indirect result of any third parties who might obtain all or part of any Report through the indemnifying Lender. In addition to the foregoing: (x) any Lender may from time to time request of Agent in writing that Agent provide to such Lender a copy of any report or document provided by Borrowers to Agent that has not been contemporaneously provided by Borrowers to such Lender, and, upon receipt of such request, Agent shall provide a copy of same to such Lender, (y) to the extent that Agent is entitled, under any provision of the Loan Documents, to request additional reports or information from Borrowers, any Lender may, from time to time, reasonably request Agent to exercise such right as specified in such Lender's notice to Agent, whereupon Agent promptly shall request of Administrative Borrower the additional reports or information reasonably specified by such Lender, and, upon receipt thereof from Administrative Borrower, Agent promptly shall provide a copy of same to such Lender, and (z) any time that Agent renders to Administrative Borrower a statement regarding the Loan Account, Agent shall send a copy of such statement to each Lender.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!